Portfolio (Quarterly)
Guide ↗
DEERFIELD MANAGEMENT COMPANY, L.P.
· CIK 0001009258| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | ACHC | ACADIA HEALTHCARE COMPANY IN | Healthcare | 4,520,000.0 | $105.7M | 1.25% | — | — | $23.39 | +10.3% |
| 22 | ARWR | ARROWHEAD PHARMACEUTICALS IN | Healthcare | 1,573,297.0 | $98.6M | 1.16% | -260K | -14.2% | $62.70 | +22.3% |
| 23 | CPRX | CATALYST PHARMACEUTICALS INC | Healthcare | 3,943,600.0 | $97.6M | 1.15% | -968K | -19.7% | $24.76 | +25.8% |
| 24 | INDV | INDIVIOR PHARMACEUTICALS INC | Healthcare | 3,097,790.0 | $94.4M | 1.11% | NEW | — | $30.48 | +24.1% |
| 25 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 1,615,696.0 | $94.0M | 1.11% | +1.1M | +198.1% | $58.15 | -3.7% |
| 26 | — | IONIS PHARMACEUTICALS INC | — | 60,000,000.0 | $90.6M | 1.07% | — | — | $1.51 | — |
| 27 | PHVS | PHARVARIS N V | Healthcare | 3,126,042.0 | $88.3M | 1.04% | — | — | $28.25 | +8.7% |
| 28 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 3,779,900.0 | $88.3M | 1.04% | NEW | — | $23.36 | -12.0% |
| 29 | TNGX | TANGO THERAPEUTICS INC | Healthcare | 4,146,813.0 | $86.8M | 1.02% | +1.2M | +42.6% | $20.92 | +18.9% |
| 30 | — | ALIGNMENT HEALTHCARE INC | — | 61,000,000.0 | $85.9M | 1.01% | — | — | $1.41 | — |
| 31 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 1,019,813.0 | $85.6M | 1.01% | NEW | — | $83.92 | +1.7% |
| 32 | PFE | PFIZER INC | Healthcare | 3,040,000.0 | $85.4M | 1.01% | NEW | — | $28.08 | -8.3% |
| 33 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 610,000.0 | $80.4M | 0.95% | -574K | -48.5% | $131.74 | +20.7% |
| 34 | DAWN | DAY ONE BIOPHARMACEUTICALS I | Healthcare | 3,723,131.0 | $79.8M | 0.94% | — | — | $21.44 | +0.4% |
| 35 | SVRA | SAVARA INC | Healthcare | 13,569,000.0 | $74.1M | 0.87% | — | — | $5.46 | -3.5% |
| 36 | — | ZENAS BIOPHARMA INC | — | 65,000,000.0 | $67.3M | 0.79% | NEW | — | $1.03 | — |
| 37 | EHAB | ENHABIT INC | Healthcare | 4,747,746.0 | $66.9M | 0.79% | — | — | $14.09 | -2.1% |
| 38 | — | NEOGENOMICS INC | — | 72,689,000.0 | $66.7M | 0.79% | — | — | $0.92 | — |
| 39 | GMAB | GENMAB A/S | Healthcare | 2,462,000.0 | $66.1M | 0.78% | NEW | — | $26.83 | +0.3% |
| 40 | BIO | BIO RAD LABS INC | Healthcare | 226,070.0 | $63.0M | 0.74% | — | — | $278.75 | -11.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%